Rice researchers unlock new insights into tellurene, paving the way for next-gen electronics

Shengxi Huang is an associate professor of electrical and computer engineering and materials science and nanoengineering at Rice University, and corresponding author on a study published in Science Advances.
Photo Credit: courtesy of Shengxi Huang/Rice University

To describe how matter works at infinitesimal scales, researchers designate collective behaviors with single concepts ⎯ like calling a group of birds flying in sync a “flock” or “murmuration.” Known as quasiparticles, the phenomena these concepts refer to could be the key to next-generation technologies.

In a recent study published in Science Advances, a team of researchers led by Shengxi Huang, associate professor of electrical and computer engineering and materials science and nanoengineering at Rice, describe how one such type of quasiparticle ⎯ polarons ⎯ behaves in tellurene, a nanomaterial first synthesized in 2017 that is made up of tiny chains of tellurium atoms and has properties useful in sensing, electronic, optical and energy devices.

“Tellurene exhibits dramatic changes in its electronic and optical properties when its thickness is reduced to a few nanometers compared to its bulk form,” said Kunyan Zhang, a Rice doctoral alumna who is a first author on the study. “Specifically, these changes alter how electricity flows and how the material vibrates, which we traced back to the transformation of polarons as tellurene becomes thinner.”

Engineering Quantum Entanglement at the Nanoscale

Study authors P. James Schuck (left) and Chiara Trovatello from the Schuck lab at Columbia Engineering.
Photo Credit: Jane Nisselson/Columbia Engineering

Physicists have spent more than a century measuring and making sense of the strange ways that photons, electrons, and other subatomic particles interact at extremely small scales. Engineers have spent decades figuring out how to take advantage of these phenomena to create new technologies.

In one such phenomenon, called quantum entanglement, pairs of photons become interconnected in such a way that the state of one photon instantly changes to match the state of its paired photon, no matter how far apart they are. 

Nearly 80 years ago, Albert Einstein referred to this phenomenon as "spooky action at a distance." Today, entanglement is the subject of research programs across the world — and it’s becoming a favored way to implement the most fundamental form of quantum information, the qubit. 

Study explains why some osteoporosis drugs may protect against Covid-19

Drugs already in-use for other conditions could help in the fight against Covid-19 and its variants
Photo Credit: Courtesy of University of York

Researchers have provided the molecular explanation for why some osteoporosis drugs offer protection against Covid-19.

Drugs already in-use for other conditions could help in the fight against Covid-19 and its variants

The study, by researchers at the University of York, builds on work conducted by Harvard Medical School that compared more than 450,000 users of a class of drugs, called bisphosphonates, with non-users during the months leading up to the pandemic in 2020. 

The Harvard study showed that those who used drugs, such as alendronate and zoledronate, had lower odds of testing for SARS-CoV-2 infection, Covid-19 diagnosis and Covid-19-related hospitalization, but the study didn’t explain why this was the case.

Tracking delivery: new technology for nanocarriers

Lipid nanoparticles visualized using SCP-Nano technology at the cellular level in lung tissue.
Image Credit: © Ali Ertürk / Helmholtz Munich

How can we ensure that life-saving drugs or genetic therapies reach their intended target cells without causing harmful side effects? Researchers at Helmholtz Munich, LMU and Technical University Munich (TUM) have taken an important step to answer this question. They have developed a method that, for the first time, enables the precise detection of nanocarriers – tiny transport vehicles – throughout the entire mouse body at a single-cell level. This innovation, called “Single-Cell Profiling of Nanocarriers” or short “SCP-Nano”, combines advanced imaging with artificial intelligence to provide unparalleled insights into the functionality of nanotechnology-based therapies. The results, published in Nature Biotechnology, pave the way for safer and more effective treatments, including mRNA vaccines and gene therapies.

Nanocarriers will play a central role in the next wave of life-saving medicines. They enable the targeted delivery of drugs, genes, or proteins to cells within patients. With SCP-Nano, researchers can analyze the distribution of extremely low doses of nanocarriers throughout the entire mouse body, visualizing each cell that has taken them up. SCP-Nano combines optical tissue clearing, light-sheet microscopy imaging, and deep-learning algorithms. First, whole mouse bodies are made transparent. After the three-dimensional imaging of whole mouse bodies, nanocarriers within the transparent tissues can then be identified down to the single-cell level. By integrating AI-based analysis, researchers can quantify which cells and tissues are interacting with the nanocarriers and precisely where this occurs.

Researchers create lab model that could lead to new, non-hormonal birth control methods

Oregon Health & Science University researchers have developed a new lab model to study how changes in cervical mucus during the menstrual cycle help regulate fertility. This model could help develop new, non-hormonal birth control methods for women.
Photo Credit: OHSU/Christine Torres Hicks

Oregon Health & Science University researchers have developed a new lab model to study how changes in cervical mucus during the menstrual cycle help regulate fertility. This model could help develop new, non-hormonal birth control methods for women.

The study, published in the journal Biology of Reproduction, is part of ongoing work by senior author Leo Han, M.D., M.P.H., associate professor of obstetrics and gynecology in the OHSU School of Medicine and the OHSU Oregon National Primate Research Center. Han is a complex family planning specialist whose research focuses on developing new, non-hormonal contraceptives. 

In this study, his research team analyzed the genetic activity in lab-cultured cervical cells, identifying hundreds of different genes that could be drug targets for birth control that uses innovative new methods to block sperm. 

Gene editing extends lifespan in mouse model of prion disease

Broad Communications Eric Minikel and Sonia Vallabh run a lab with a singular focus: preventing and treating prion disease within their lifetime.
Photo Credit: Maria Nemchuk

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal neurodegenerative condition. The treatment, which uses base editing to make a single-letter change in DNA, reduced levels of the disease-causing prion protein in the brain by as much as 60 percent. 

There is currently no cure for prion disease, and the new approach could be an important step towards treatments that prevent the disease or slow its progression in patients who have already developed symptoms. A base-editing approach could also likely be a one-time treatment for all prion disease patients regardless of the genetic mutation causing their disease. 

The work, led by Broad senior group leaders Sonia Vallabh and Eric Minikel, as well as Broad core institute member David Liu, is the first demonstration that lowering levels of the prion protein improves lifespan in animals that have been infected with a human version of the protein. The findings appear in Nature Medicine.

NIH-funded study finds cases of ME/CFS increase following SARS-CoV-2

Photo Credit: Bruno Aguirre

New findings from the National Institutes of Health’s (NIH) Researching COVID to Enhance Recovery (RECOVER) Initiative suggest that infection with SARS-CoV-2, the virus that causes COVID-19, may be associated with an increase in the number of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases. According to the results, 4.5% post-COVID-19 participants met ME/CFS diagnostic criteria, compared to 0.6% participants that had not been infected by SARS-CoV-2 virus.  RECOVER is NIH’s national program to understand, diagnose, prevent, and treat Long COVID.

The research team, led by Suzanne D. Vernon, Ph.D., from the Bateman Horne Center in Salt Lake City, examined adults participating in the RECOVER adult cohort study to see how many met the IOM clinical diagnostic criteria for ME/CFS at least six months after their infection. Included in the analysis were 11,785 participants who had been infected by SARS-CoV-2 and 1,439 participants who had not been infected by the virus. Findings appear in the Journal of General Internal Medicine.

Inorganic and biocatalysts work together to reduce CO2

First author Panpan Wang tested the catalysis cascade in the laboratory.
Photo Credit: Ruhr-Universität Bochum / Marquard

In a hybrid cascade, climate-damaging CO2 is turned back into valuable methanol. An international research team has shown how this works. 

In order to recover valuable substances from CO2, it must be reduced in many individual steps. If electrocatalysis is used for this, many potentially different potential molecules are formed, which cannot necessarily be used. Biocatalysts, on the other hand, are selective and only produce one product – but they are also very sensitive. An international research team led by Professor Wolfgang Schuhmann from the Center for Electrochemistry at Ruhr-Universität Bochum, Germany, and Dr. Felipe Conzuelo from the Universidade Nova de Lisboa, Portugal, has developed a hybrid catalysis cascade that makes use of the advantages of both processes. The researchers report in the journal “Angewandte Chemie Interational Edition” from December 23, 2024.

Polygamy is (not) for the birds

Rafael S. Marcondes, a faculty fellow in ecology and evolutionary biology at Rice
Photo Credit: Alex Becker/Rice University

Researchers at Rice University have uncovered new insights into the evolution of bird behavior, revealing why certain mating systems persist while others disappear over time. In a recent paper published in the journal Evolution, Rafael S. Marcondes and Nicolette Douvas reveal that lekking — a mating system where males display for females without forming lasting bonds — is an evolutionarily stable strategy. In contrast, resource-defense polygamy, where one sex — usually but not always the male — guards territories to attract mates, is highly unstable and often reverts to monogamy.

“This research not only examines how mating behaviors influence species survival but also sheds light on larger evolutionary questions,” said Marcondes, the corresponding author and a faculty fellow in ecology and evolutionary biology at Rice. “By studying birds, we’re uncovering principles that may resonate across other species too.”

The study analyzed data from more than 60% of the world’s bird species — approximately 6,620 species — making it one of the most comprehensive analyses of its kind.

Oxford researchers develop blood test to enable early detection of multiple cancers

Photo Credit: Fernando Zhiminaicela

Oxford University researchers have unveiled a new blood test, powered by machine learning, which shows real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect.

Named TriOx, this innovative test analyses multiple features of DNA in the blood to identify subtle signs of cancer, which could offer a fast, sensitive and minimally invasive alternative to current detection methods.

The study, published in Nature Communications, showed that TriOx accurately detected cancer (including in its early stages) across six cancer types and reliably distinguished those people who had cancer from those that did not.

Cancers are more likely to be cured if they’re caught early, and early treatment is also much cheaper for healthcare systems. While the test is still in the development phase, it demonstrates the promise of blood-based early cancer detection, a technology that could revolutionize screening and diagnostic practices.

A team of researchers at the University of Oxford have developed a new liquid biopsy test capable of detecting six cancers at an early stage. The cancer types evaluated in this study were colorectal, esophageal, pancreatic, renal, ovarian and breast.